IPO - RHYTHM PHARMACEUTICALS, INC.

Add to your watchlist
Back to List of IPO Filings

Form Type: 424B5

Filing Date: 2025-07-10

Corporate Action: Ipo

Type: New

Accession Number: 000110465925067023

Filing Summary: Rhythm Pharmaceuticals, Inc. is offering 2,058,824 shares of common stock at a public offering price of $85.00 per share, raising approximately $164.1 million in net proceeds. The offering is facilitated through underwriters including Morgan Stanley and BofA Securities. The net proceeds are intended to support the clinical development of their product candidates, particularly IMCIVREE, and for general corporate purposes. As of July 9, 2025, the last reported sale price for the common stock was $89.00 per share. The company has not paid dividends historically and does not plan to do so in the foreseeable future. This prospectus supplement updates the information from a prior prospectus dated March 2, 2023, and indicates that individual risks for investors are associated with the offerings, including the potential for substantial dilution.

Additional details:

Public Offering Price: 85

Total Proceeds: 175000040

Underwriting Discounts And Commissions: 10

>< }]}]}]}]}]}]}]}]} }]}]}]} }]}]} }]}]}]} }]}]}]} }]}]}]} }]}]}]} } Craft Craft Craft Craft }]}]}]}]}]}]} }]}]}]}]}]}]} }]}]}]}]}]}]}]} }]}]}]}]}]}]}]} }]}]}]}]}]}]}]} }]}]}]}]}]}]}]} }]}]}]}]}]}]}]} }]}]}]}]}]}] ]) ) ] } ] ] } ] ]}}}}}: 1

]' Immediate Dilution, : : ) prognosis ' ” .} 1 ` 424B5 = Version 1.0.1`, .. ...          ` Participants may review records subject to appropriate prior written consent. 1}][' :

Comments

No comments yet. Be the first to comment!